Biovascular Devices Research Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 30 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -17.13%
- Ebitda -17.13%
- Net Worth -12.94%
- Total Assets 0.77%
About Biovascular Devices Research
Biovascular Devices Research Limited (BDRL) is a Public Limited Indian Non-Government Company incorporated in India on 02 January 1995 and has a history of 30 years and one month. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U73100GJ1995PLC024048
-
Company No.
024048
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
02 Jan 1995
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Biovascular Devices Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashantbhai Hastak
|
Director | 02-Jan-1995 | Current |
|
Pranesh Hastak
|
Director | 22-Jun-2013 | Current |
|
Kalpesh Shah
|
Director | 22-Jun-2013 | Current |
Financial Performance of Biovascular Devices Research.
Biovascular Devices Research Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 17.13% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biovascular Devices Research?
In 2023, Biovascular Devices Research had a promoter holding of 91.39% and a public holding of 8.61%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aceto Tex-Chem Private LimitedPrashantbhai Hastak is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Biovascular Devices Research?
Unlock and access historical data on people associated with Biovascular Devices Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biovascular Devices Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biovascular Devices Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.